• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE MOLECULAR SYSTEMS, INC COBAS TAQSCREEN MPX TEST, V2.0 CE-IVD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE MOLECULAR SYSTEMS, INC COBAS TAQSCREEN MPX TEST, V2.0 CE-IVD Back to Search Results
Catalog Number 05969492190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Information (3190)
Event Date 07/11/2017
Event Type  malfunction  
Manufacturer Narrative
An (b)(6) customer alleged the generation of a (b)(6) result with the cobas taqscreen mpx test v2.0 ce-ivd (lot 225191) for a donor sample, when tested in a pool of 1.The donor sample generated (b)(6) serology results for (b)(6) and upon repeat testing with the cobas taqscreen mpx test v2.0 ce-ivd (lot 225191), an (b)(6) reactive result was obtained.The blood associated with this donor was discarded and no harm was alleged.Through the course of the investigation, sample was requested from the customer for further testing; however, as the blood was discarded there was no additional sample left.The retain kit lot (225191) was tested and met specifications; no (b)(6) results were generated.No kit issues were identified in the review of the qc kit release data generated for this lot, and there were no related internal non-conformances.Possible issues that could lead to no amplification of targets or suppression of the ic include work flow issues during sample prep, dust, contamination or other pcr inhibitors (e.G.Heparin, dna away).The udi for the cobas taqscreen mpx test, v2.0 ce-ivd is (b)(4).The corresponding us kit material number is (b)(4).(b)(4).
 
Event Description
A customer in (b)(6) reported a result discrepancy during use of the mpxv2 assay.On (b)(6) 2017 the customer tested a pp6 which generated a (b)(6) result for (b)(6) (ct.23.2).Resolution pooling (resp1) was performed on (b)(6) 2017 and all samples in the pool generated (b)(6) results.Due to the fact that serology was (b)(6) for the donor, on (b)(6) 2017, a new aliquot (from the same withdrawal) was tested in pp1.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS TAQSCREEN MPX TEST, V2.0 CE-IVD
Type of Device
NA
Manufacturer (Section D)
ROCHE MOLECULAR SYSTEMS, INC
1080 us highway 202 south
branchburg NJ 08876
Manufacturer Contact
stacie-ann creighton
1080 us hwy 202 s
na
branchburg, NJ 08876
9082537112
MDR Report Key6789403
MDR Text Key83108701
Report Number2243471-2017-00020
Device Sequence Number1
Product Code PPM
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/11/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/31/2018
Device Catalogue Number05969492190
Device Lot Number225191
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 07/17/2017
Initial Date FDA Received08/11/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-